Clinical Trials Sponsored by Danilo Toni

Total 2366 results

University of Copenhagen
The Danish Medical Research Council; Danisco

Completed

The Effect of Probiotics on Low-grade Inflammation, Microbiota and Risk Factors for Metabolic Syndrome in Obese Children

Inflammation | Obesity | Metabolic Syndrome

Denmark
Universidade Católica Portuguesa
Danilo Fernandes

Completed

Multi-level Dimensional Changes at Immediate Implant Sites

Dental Implant Failed

Portugal
University of Oldenburg
Danilo Postin, M.Sc.

Recruiting

Neural Correlates of Social Touch and Interoceptive Perception as Potential Biomarker for Impaired Social Functioning (SPIRIT)

Schizophrenia

Germany
Daniel Muñoz-Garcia
Camilo Jose Cela University

Completed

Effects of Vibration Foam Rolling After Muscle Damage

Pain, Acute

Spain
Danisco

Completed

Effect of Probiotic Supplementation on Lactose Maldigestion Induced by Lactose Solution

Lactose Intolerance

France
Danisco

Completed

Effect of Probiotic Supplement in Alleviating Functional Gastrointestinal Symptoms

Irritable Bowel Syndrome

Finland
Danisco

Terminated

Effect of Probiotic Formula on Reducing the Risk for Antibiotic-associated Diarrhoea

Antibiotic-associated Diarrhoea

Finland
Danisco

Completed

The Effect of a Bifidobacterium and Polydextrose on Body Fat Mass (MetSProb)

Hyperglycemia | Obesity | Insulin Resistance

Finland
Danisco

Completed

Effect of Three Fibres on Glycaemic and Insulinaemic Responses in Healthy Adult Volunteers

Healthy Volunteers

United Kingdom
Danisco

Terminated

Effect of Probiotic Supplement on Bowel Function (IBS2)

Irritable Bowel Syndrome

Finland
Danisco

Completed

Probiotics and Endotoxemia (PROMS-01)

Metabolic Syndrome | Metabolic Endotoxemia

France
Danisco

Completed

Vitamin K2 Intervention in Patients With Vitamin K Antagonists (SAFEK)

Thrombosis

France
Danisco

Completed

Probiotics for Birch Pollen Allergy

Rhinitis, Allergic, Seasonal

Finland
Danisco

Completed

Evaluation of Probiotics on Symptoms of Upper Respiratory Tract Infections

Healthy

China
Danilo Toni
Boehringer Ingelheim; Associazione Italiana Aritmologia e Cardiostimolazione... and other collaborators

Completed

Detection of Silent Atrial Fibrillation aFter Ischemic StrOke (SAFFO)

Cerebrovascular Disorders | Central Nervous System Diseases | Nervous System Diseases | Ischemic Stroke | Brain Ischemia | Cerebral Infarction | Brain Infarction | Cardiac Arrhythmias | Brain Disease

Italy
Dr Milutin Bulajic

Completed

Assessing Endoloop-assisted Polypectomy in Patients With Antiplatelet Therapy

Colorectal Polyp
Danish Study Group
Danish Heart Foundation

Completed

Efficacy of Implantable Cardioverter Defibrillator in Patients With Non-ischemic Systolic Heart Failure on Mortality (DANISH)

Heart Failure | Dilated Cardiomyopathy | Reduced LVEF

Denmark
Danish Study Group
Danish Heart Foundation

Completed

Danish ICD Study in Patients With Dilated Cardiomyopathy (DANISH)

Heart Failure | Dilated Cardiomyopathy | Reduced LVEF

Denmark
Danisco
BioFortis

Completed

Effect of an 8-week Bifidobacterium Lactis HN019 Supplementation on Functional Constipation (BifidoDigest)

Functional Constipation

France
Toni Choueiri, MD

Withdrawn

STA-9090 in Castration-Resistant Prostate Cancer With Assessment of Androgen Receptor Pathway Signaling

Adenocarcinoma of the Prostate

United States
Université NAZI BONI

Not yet recruiting

Effects of Perioperative Administration of Intravenous Lidocaine in Children Operated on for Acute Generalized Peritonitis

Postoperative Pain
Tonix Pharmaceuticals, Inc.

Completed

A Phase 2 Study to Evaluate the Efficacy and Safety of TNX-102 SL in Patients With Multi-Site Pain Associated With Post-Acute Sequelae of SARS-CoV-2 Infection (PREVAIL)

COVID-19 | Long COVID | Post-Acute Sequelae of SARS-CoV-2 (PASC) Infection | Long Haul COVID

United States
Tonix Pharmaceuticals, Inc.

Completed

A Study To Evaluate The Efficacy And Safety Of TNX-102 SL In Patients With Fibromyalgia (RELIEF)

Fibromyalgia

United States
Université NAZI BONI

Completed

Opioid Free Anesthesia in Maxillofacial Surgery

Maxillofacial Surgery

Burkina Faso
Tonix Pharmaceuticals, Inc.

Completed

A 40-week Study to Evaluate TNX-102 SL 5.6 mg Taken Daily at Bedtime in Patients With PTSD (P306)

PTSD

United States
Tonix Pharmaceuticals, Inc.

Terminated

Repeat of: A Study to Evaluate Efficacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With Fibromyalgia (RE-AFFIRM)

Nervous System Diseases | Musculoskeletal Diseases | Rheumatic Diseases | Muscular Diseases | Neuromuscular Diseases | Fibromyalgia | Myofascial Pain Syndromes

United States
Tonix Pharmaceuticals, Inc.

Completed

Steady-State Pharmacokinetic Comparison Study of TNX-102 SL 5.6 mg Versus AMRIX® 30 mg ER Capsules

Healthy Subjects

Canada
Tonix Pharmaceuticals, Inc.

Completed

A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia (AFFIRM)

Nervous System Diseases | Musculoskeletal Diseases | Rheumatic Diseases | Muscular Diseases | Neuromuscular Diseases | Fibromyalgia | Myofascial Pain Syndromes

United States
Tonix Pharmaceuticals, Inc.

Completed

Open Label Extension Safety and Efficacy Study of TNX-102 SL Tablets in Military Related PTSD and Related Conditions (P202)

PTSD

United States
Tonix Pharmaceuticals, Inc.

Completed

Safety and Efficacy Study of TNX-102 SL in Subjects With Military-Related PTSD and Related Conditions (AtEase)

PTSD

United States
Tonix Pharmaceuticals, Inc.

Completed

Comparative Pharmacokinetics and Safety of 3 Different Formulations of TNX-102 2.8 mg SL Tablets and Cyclobenzaprine 5 mg Oral Tablet in Healthy Adults

Healthy Adults

Canada
Tonix Pharmaceuticals, Inc.

Completed

Comparative Pharmacokinetics and Safety of TNX-102 SL Tablets and Cyclobenzaprine Oral Tablet in Healthy Adults

Healthy Adults

Canada
Tonix Pharmaceuticals, Inc.

Completed

Comparative Bioavailability of Sublingual TNX-102, Oral and Intravenous Cyclobenzaprine in Healthy Adults

Healthy Adults

Canada
Tonix Pharmaceuticals, Inc.

Completed

A Phase 3 Study To Evaluate The Efficacy And Safety Of TNX-102 SL In Patients With Fibromyalgia (RALLY)

Fibromyalgia

United States
Tonix Pharmaceuticals, Inc.

Withdrawn

Safety and Efficacy Study of TNX-102 SL in Participants With PTSD

PTSD

Kenya
Tonix Pharmaceuticals, Inc.

Completed

Bioequivalence Study of TNX-102 SL 2.8 mg Sublingual Tablets From Two Manufacturers.

Healthy Adults

Canada
Tonix Pharmaceuticals, Inc.

Terminated

A 3-Month Open-Label Safety and Efficacy Study of TNX-102 SL Tablets in Fibromyalgia Patients

Primary Fibromyalgia

United States
Tonix Pharmaceuticals, Inc.

Completed

Phase 1 Single Ascending Dose Safety Study of TNX-201 Capsules in Healthy Volunteers

Healthy
Tonix Pharmaceuticals, Inc.

Completed

A Phase 3 Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily in Patients With Fibromyalgia (RESILIENT)

Fibromyalgia

United States
Université NAZI BONI

Completed

Transverse Abdominal Plane Block for Caesarean

Caesarean Section; Pain

Burkina Faso
Tonix Pharmaceuticals, Inc.

Withdrawn

An Open-Label, Randomized Pilot Study Comparing the Safety of a Single Dose of TNX-1300 to Usual Care (UC) Alone for the Treatment of Signs and Symptoms of Acute Cocaine Intoxication in Male Emergency Department (ED) Subjects

Cocaine Intoxication

United States
Tonix Pharmaceuticals, Inc.

Terminated

A Phase 3 Study to Evaluate the Efficacy and Safety of TNX-102 SL in Participants With PTSD (RECOVERY)

PTSD

United States
Tonix Pharmaceuticals, Inc.

Completed

Dose-Proportionality and Food Effect Study of TNX-102 SL

Healthy Subjects

Canada
Tonix Pharmaceuticals, Inc.

Completed

A Comparative Bioavailability and Pharmacokinetic Study of TNX-102 2.4 mg and Cyclobenzaprine 5 mg Tablets in Healthy Adults.

Healthy

Canada
Tonix Pharmaceuticals, Inc.

Completed

12-Month Open-Label Long-term Safety Study of TNX-102 SL Tablets in Fibromyalgia Patients (BESTFIT-OLE)

Primary Fibromyalgia

United States
Tonix Pharmaceuticals, Inc.

Completed

Safety and Efficacy Study of TNX-201 Capsules for Treatment of Single Tension-Type Headache

Tension-Type Headache

United States
Tonix Pharmaceuticals, Inc.

Completed

BEdtime Sublingual TNX-102 SL as Fibromyalgia Intervention Therapy (BESTFIT) (BESTFIT)

Primary Fibromyalgia

United States
Enrico De Toni

Recruiting

Sequential or Up-front Triple Treatment With Durvalumab, Tremelimumab and Bevacizumab for Non-resectable Hepatocellular Carcinoma (HCC) Patients (MONTBLANC)

Hepatocellular Carcinoma

Germany
Danish Breast Cancer Cooperative Group
Danish Cancer Society

Active, not recruiting

Hypofractionated Loco-regional Adjuvant Radiation Therapy of Breast Cancer Combined With a Simultaneous Integrated Boost

Fibrosis | Lymphedema

Denmark
Danish Headache Center

Recruiting

Hypersensitivity to Phosphodiesterase 3 Inhibition in Post-Traumatic Headache

Post-Traumatic Headache

Denmark

3

Subscribe